Iron deficiency anaemia (IDA) has been observed concomitantly with unexplained leukopenia. However, this association is limited in literature. We investigated the association between IDA and leukopenia and explored iron therapy as a novel approach to improving immune function in patients with leukopenia....

Multiple myeloma is a potentially fatal hematological malignancy characterized by clonal growth of terminally differentiated B cells. The development of novel medicines (proteasome inhibitors, immunomodulatory medications, antibodies targeting cell surface molecules, and autologous stem cell transplantation) has improved patients' quality of life and overall survival rate with multiple myeloma. Despite the advancement of these new therapies that help resolve disease progression and hence provide...